AEIS AI Fracture Robot Crowned 'Next-Generation World-Class'

AIRS's innovative AI-powered fracture surgery robot system, which leads future medicine, has finally been honored with the prestigious title of '2025 Next-Generation World-Class Product'! This achievement will be a significant milestone, so...

Nov 20, 2025 - 00:00
 0  916
AEIS AI Fracture Robot Crowned 'Next-Generation World-Class'
AIRS's innovative AI-powered fracture surgery robot system, which leads future medicine, has finally been honored with the prestigious title of '2025 Next-Generation World-Class Product'! This achievement will be a significant milestone, solidifying AIRS's unique technological prowess and market potential globally. Notably, at the awards ceremony recently held at Lotte Hotel World in Seoul, AIRS showcased its prominence as an AI showcase exhibition company and garnered keen interest by directly presenting a blueprint for future medicine. AIRS's fracture surgery support robot system was developed to dramatically reduce the high difficulty of traditional fracture surgeries and the reliance on medical professionals' expertise. An AI navigation system precisely designs an optimized surgical path for each patient, while ultra-precise robotic arms perfectly align the fracture site without error, enabling accurate and safe surgery. As a result, it maximizes safety by drastically reducing radiation exposure for both medical staff and patients by as much as tenfold. Furthermore, it provides multifaceted innovations such as dramatically improving surgical accuracy and efficiency to shorten operating times, and significantly reducing the fatigue of medical professionals. AIRS is not stopping there; it is preparing for a robust leap into the global medical market. Currently, it is conducting successful clinical trials in Israel and Singapore and is on the verge of receiving approval from international regulatory bodies. It is also actively exploring technology exchange and cooperation strategies with hospitals, medical experts, and leading investment institutions in key hub countries worldwide, including the United States, Europe, and the Middle East, preparing to lead global standards. Jeong Sang-hyeon, CEO of AIRS, expressed confidence through this selection, stating, "AIRS's technological prowess and marketability in the field of orthopedic surgery have been recognized simultaneously." He further unveiled his vision: "We will continuously enhance the precision and stability of surgeries based on AI and robotic technology, and secure overwhelming global competitiveness." The horizons of future medicine that AIRS will create are highly anticipated!

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0